Antibiotic Choice for Acute Bacterial Sinusitis
Amoxicillin-clavulanate at high-dose (2 g orally twice daily for adults or 90 mg/kg/day orally twice daily for children) is the recommended first-line antibiotic for acute bacterial rhinosinusitis (ABRS), with treatment duration of 5-7 days in adults and 10-14 days in children. 1
First-Line Antibiotic Therapy
The 2012 IDSA guideline establishes amoxicillin-clavulanate as superior to amoxicillin alone for both adults (weak recommendation) and children (strong recommendation) 1. High-dose formulation is specifically indicated when:
- Recent antibiotic use within 4-6 weeks
- Geographic areas with >10% penicillin-nonsusceptible S. pneumoniae
- Severe infection (fever >39°C, systemic toxicity)
- Age >65 years
- Recent hospitalization
- Immunocompromised status 2
The high-dose regimen overcomes resistance from penicillin-resistant S. pneumoniae, β-lactamase-producing H. influenzae, and M. catarrhalis 3.
Penicillin Allergy Alternatives
For severe (Type I) penicillin allergy:
For non-Type I hypersensitivity:
- Combination therapy: Clindamycin PLUS third-generation oral cephalosporin (cefixime or cefpodoxime) 2
Critical caveat: Macrolides (azithromycin, clarithromycin) and trimethoprim-sulfamethoxazole are NOT recommended due to high resistance rates—>40% for macrolides against S. pneumoniae and 50% for TMP-SMX 2. Despite this strong evidence against their use, they remain commonly prescribed, representing a significant stewardship failure.
Treatment Duration
- Adults: 5-7 days (weak evidence, but shorter courses reduce adverse events by 21% compared to 10 days) 1, 2
- Children: 10-14 days (weak evidence, but longer duration remains standard) 1
Adjunctive Intranasal Corticosteroid Therapy
Intranasal corticosteroids ARE recommended as adjunctive therapy to antibiotics, particularly in patients with allergic rhinitis history 1. This recommendation carries moderate-quality evidence and provides meaningful symptom relief by addressing the inflammatory component of ABRS.
Saline nasal irrigation (physiologic or hypertonic) is also recommended as adjunctive treatment in adults 1.
What NOT to Use
The guidelines are explicit about avoiding:
- Topical or oral decongestants
- Antihistamines
- Routine MRSA coverage (not indicated despite S. aureus being a potential pathogen) 1
These carry a strong recommendation against use with low-moderate quality evidence.
Treatment Failure Algorithm
Reassess if:
- Symptoms worsen after 48-72 hours
- No improvement after 3-5 days 1
Switch to:
- Respiratory fluoroquinolone (levofloxacin, moxifloxacin, or gatifloxacin)
- High-dose amoxicillin-clavulanate (if not already used)
- Ceftriaxone
- Consider sinus aspiration for culture 3
Specialist Referral Indications
Refer to otolaryngology, infectious disease, or allergy when patients are:
- Seriously ill or immunocompromised
- Deteriorating despite extended antibiotic courses
- Experiencing recurrent episodes with clearing between 1
Key Clinical Pitfall
The most common error is prescribing antibiotics for viral rhinosinusitis. Only prescribe antibiotics when ABRS criteria are met: persistent symptoms >10 days, severe symptoms (fever >39°C + purulent discharge + facial pain) for ≥3 consecutive days, or "double-sickening" (worsening after initial improvement at day 5-6) 4, 5. Most acute rhinosinusitis is viral and self-limited within 7-10 days—antibiotic overuse drives resistance without improving outcomes 5, 6.
The number needed to treat for rapid cure is 18, while number needed to harm from adverse effects is only 8 4, emphasizing the importance of appropriate patient selection.